We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Wegovy improved functional class vs. placebo at 1 year ...
Panelists discuss how GLP-1 receptor agonists show promising benefits for patients with HFpEF, particularly those with obesity-related disease, through significant weight loss and improved functional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results